BRIEF-Intellipharmaceutics/ Par to commercially launch 15 and 30 mg generic Focalin XR

Mon Nov 18, 2013 4:42pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 18 (Reuters) - Intellipharmaceutics International Inc : * / Par to make immediate commercial launch of 15 and 30 mg generic Focalin

XR(R) * FDA granted final approval of dexmethylphenidate hydrochloride

extended-release capsules for 15 and 30 mg strengths * Co's dexmethylphenidate hydrochloride extended-release capsules 5, 10, 20 and

40 mg strengths were also tentatively FDA approved * Source text for Eikon * Further company coverage